Literature DB >> 16628616

Trigeminovestibular and trigeminospinal pathways in rats: retrograde tracing compared with glutamic acid decarboxylase and glutamate immunohistochemistry.

Monique Diagne1, Jocelyne Valla, Christian Delfini, Catherine Buisseret-Delmas, Pierre Buisseret.   

Abstract

This study identified neurons in the sensory trigeminal complex with connections to the medial (MVN), inferior (IVN), lateral (LVN), and superior (SVN) vestibular nuclei or the spinal cord. Trigeminovestibular and trigeminospinal neurons were localized by injection of retrograde tracers. Immunohistochemical processing revealed gamma-aminobutyric acid (GABA)- and glutamate-containing neurons in these two populations. Trigeminovestibular neurons projecting to the MVN and the IVN were in the caudal principal nucleus (5P), pars oralis (5o), interpolaris (5i), and caudalis (5c) and scattered throughout the rostral 5P. Projections were bilateral to the IVN, with an ipsilateral dominance to the MVN, except from the rostral 5P, which was contralateral. Neurons projecting to the LVN were numerous in the ventral caudal 5P and the 5o and less abundant in the rostral 5P, 5i, and 5c. Our results suggested that only 5P and 5o project to the dorsal LVN. Neurons projecting to the SVN were in the dorsal 5P, 5o, and 5i but not in 5c. Trigeminospinal neurons were mainly in the ventral 5o and 5i and in the lateral 5c, rarely or never in 5P. Among trigeminovestibular neurons, most of the somas were immunoreactive for glutamate, but some reacted for GABA. Among trigeminospinal neurons, the number of somas immunoreactive for each of the two amino acids was similar. Trigeminal terminals were observed in contact with vestibulospinal neurons in the IVN and LVN, giving evidence of a trigeminovestibulospinal pathway. Therefore, inhibitory and excitatory facial inputs may contribute through trigeminospinal or trigeminovestibulospinal pathways to the control of head/neck movements. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628616     DOI: 10.1002/cne.20964

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  5 in total

1.  Oral splint therapy in patients with Menière's disease and temporomandibular disorder: a long-term, controlled study.

Authors:  Edoardo Bernkopf; Vincenzo Capriotti; Giulia Bernkopf; Emilia Cancellieri; Andrea D'Alessandro; Alberto Vito Marcuzzo; Caterina Gentili; Giovanni Carlo De Vincentiis; Giancarlo Tirelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-26       Impact factor: 3.236

2.  Craniomandibular System and Postural Balance after 3-Day Dry Immersion.

Authors:  Loïc Treffel; Liubov Dmitrieva; Guillemette Gauquelin-Koch; Marc-Antoine Custaud; Stéphane Blanc; Claude Gharib; Catherine Millet
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

3.  Oral Implant-Prostheses: New Teeth for a Brighter Brain.

Authors:  Vincenzo De Cicco; Massimo Barresi; Maria Paola Tramonti Fantozzi; Enrico Cataldo; Vincenzo Parisi; Diego Manzoni
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

4.  Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model.

Authors:  Ruimin Tian; Yun Zhang; Qi Pan; Yunfeng Wang; Qianwen Wen; Xiaoping Fan; Guangcheng Qin; Dunke Zhang; Lixue Chen; Yixin Zhang; Jiying Zhou
Journal:  J Headache Pain       Date:  2022-03-08       Impact factor: 7.277

5.  Occlusal splint therapy in patients with Ménière's disease and temporomandibular joint disorder.

Authors:  Daniele Monzani; Carlo Baraldi; Enrico Apa; Matteo Alicandri-Ciufelli; Carlo Bertoldi; Elisabeth Röggla; Simona Guerzoni; Daniele Marchioni; Luca Pani
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-02-07       Impact factor: 2.618

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.